Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Charleston, SC
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Memphis, TN
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Bellevue, WA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Bothell, WA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Bothell, WA
Click here to add this to my saved trials
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/17/2015
QPS MRA
mi
from
Miami, FL
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/17/2015
QPS MRA
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/17/2015
Houston Clinical Research
mi
from
Houston, TX
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/17/2015
Houston Clinical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/17/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/17/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Association of Amino Acid Prevalence and Chronic Brain Injury
Association of Amino Acid Prevalence and Chronic Brain Injury
Status: Enrolling
Updated:  11/17/2015
Centre for Neuro Skills
mi
from
Bakersfield, CA
Association of Amino Acid Prevalence and Chronic Brain Injury
Association of Amino Acid Prevalence and Chronic Brain Injury
Status: Enrolling
Updated: 11/17/2015
Centre for Neuro Skills
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Association of Amino Acid Prevalence and Chronic Brain Injury
Association of Amino Acid Prevalence and Chronic Brain Injury
Status: Enrolling
Updated:  11/17/2015
Centre for Neuro Skills
mi
from
Dallas, TX
Association of Amino Acid Prevalence and Chronic Brain Injury
Association of Amino Acid Prevalence and Chronic Brain Injury
Status: Enrolling
Updated: 11/17/2015
Centre for Neuro Skills
mi
from
Dallas, TX
Click here to add this to my saved trials
Association of Amino Acid Prevalence and Chronic Brain Injury
Association of Amino Acid Prevalence and Chronic Brain Injury
Status: Enrolling
Updated:  11/17/2015
Transitional Learning Center
mi
from
Galveston, TX
Association of Amino Acid Prevalence and Chronic Brain Injury
Association of Amino Acid Prevalence and Chronic Brain Injury
Status: Enrolling
Updated: 11/17/2015
Transitional Learning Center
mi
from
Galveston, TX
Click here to add this to my saved trials
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Status: Enrolling
Updated:  11/18/2015
Tuscaloosa VA Medical Center
mi
from
Tuscaloosa, AL
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Status: Enrolling
Updated: 11/18/2015
Tuscaloosa VA Medical Center
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Status: Enrolling
Updated:  11/18/2015
Tuscaloosa Veterans Affairs Medical Center
mi
from
Tuscaloosa, AL
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Status: Enrolling
Updated: 11/18/2015
Tuscaloosa Veterans Affairs Medical Center
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Status: Enrolling
Updated:  11/18/2015
VA Medical Center, Tuscaloosa
mi
from
Tuscaloosa, AL
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Status: Enrolling
Updated: 11/18/2015
VA Medical Center, Tuscaloosa
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University of California, Irvine
mi
from
Irvine, CA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
Forbes Norris MDA/ALS Research Center
mi
from
San Francisco, CA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
Forbes Norris MDA/ALS Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
Massachusetts General Hospitals
mi
from
Boston, MA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
Massachusetts General Hospitals
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
Ohio State University
mi
from
Columbus, OH
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
Penn State College of Medicine, Milton S. Hershey Medical Center
mi
from
Hershey, PA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
Penn State College of Medicine, Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
Nerve and Muscle Center of Texas
mi
from
Houston, TX
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
Nerve and Muscle Center of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University Health Sciences Center, San Antonio
mi
from
San Antonio, TX
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University Health Sciences Center, San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University of Virginia
mi
from
Charlottesville, VA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University California San Francisco
mi
from
Fresno, CA
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University California San Francisco
mi
from
Fresno, CA
Click here to add this to my saved trials
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated:  11/18/2015
University of Toronto
mi
from
Toronto,
Efficacy of Methotrexate in Myasthenia Gravis
Phase II Trial of Methotrexate in Myasthenia Gravis
Status: Enrolling
Updated: 11/18/2015
University of Toronto
mi
from
Toronto,
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US053
mi
from
Phoenix, AZ
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US053
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US081
mi
from
Castro Valley, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US081
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US089
mi
from
La Jolla, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US089
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US043
mi
from
Loma Linda, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US043
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US008
mi
from
Los Angeles, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US008
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US020
mi
from
Palo Alto, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US020
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US050
mi
from
Pasadena, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US050
mi
from
Pasadena, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US098
mi
from
Santa Barbara, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US098
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US051
mi
from
Thousand Oaks, CA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US051
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US068
mi
from
Englewood, CO
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US068
mi
from
Englewood, CO
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US063
mi
from
Fairfield, CT
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US063
mi
from
Fairfield, CT
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US104
mi
from
New Haven, CT
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US104
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US049
mi
from
Pensacola, FL
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US049
mi
from
Pensacola, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US109
mi
from
Atlanta, GA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US109
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US042
mi
from
Augusta, GA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US042
mi
from
Augusta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US052
mi
from
Columbus, GA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US052
mi
from
Columbus, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US080
mi
from
Decatur, GA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US080
mi
from
Decatur, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US040
mi
from
Lawrenceville, GA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US040
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US067
mi
from
Macon, GA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US067
mi
from
Macon, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated:  11/18/2015
US085
mi
from
Savannah, GA
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke
Status: Enrolling
Updated: 11/18/2015
US085
mi
from
Savannah, GA
Click here to add this to my saved trials